This newest twist within the Lykos Therapeutics saga threatens a major overhaul of the company’s strategy and course, with Musk ally and billionaire investor Antonio Gracias appearing to desire to choose the corporate again toward its nonprofit drug advancement roots and a far more Doblinite philosophy.A patent application from psychological heal